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CHAPTER I 
1.INTRODUCTION 
1.1 Hyperlipidemia 
Hyperlipidemia is a disorder of lipid metabolism manifested by increase of 
plasma concentrations of the various lipid and lipoprotein fractions such as 
increase of serum total cholesterol (TC), low-density lipoprotein (LDL), 
triglyceride (TG) concentrations, and a decrease in the high-density 
lipoprotein (HDL) concentration. Hyperlipidemia is the key risk factor for 
cardiovascular disorders and has been reported as the most common cause 
of death in developed as well as developing nations. Hyperlipidemia may be 
caused by specific genetic abnormalities called primary hyperlipidemia6 or 
may be idiopathic caused by lifestyle habits or medical diseases such as 
diabetes, kidney disease, pregnancy, hypothyroidism and heart disease. 
Hyperlipidemia prevalence continued to increase annually, requiring the 
develop-ment of drugs capable of lowering blood lipids to reduce mortality and 
morbidity due to cardiovascular complications. Although synthetic lipid-
lowering drugs are useful in treating hyperlipidemia, there are number of 
adverse effects. So, the cur-rent interest has stimulated the search for new 
lipid-lowering agents with minimal side effects from natural sources. 
Herbal medicines are the oldest remedies known to mankind. Herbs had been 
used by all cultures throughout history. In the last few years, there has been 
an exponential growth in the field of herbal medicine and these drugs are 
gaining popularity both in developing and developed countries because of 
their natural origin and less side effects when comparing other system of 
medicine. India being the botanical garden of the world with more than 2400 
medicinal plants out of 21000 species being listed by WHO, is the largest 
producer of medicinal plants around the globe. 
Artocarpus heterophyllusis a large, evergreen tree, 10-15m in height, 
indigenous to the evergreen forests at altitude of 450-1,200m and cultivated 
throughout the hotter parts of India. Stem of this plant is straight rough 
whereas bark is green or black, 1.25cm thick, exuding milky latex, leaves 
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broad obovate, elliptic, decurrent, glabrous, entire inflorescence solitary 
axillaries, cauliforous and ramflours on short leafy shoots. Male head is 
sessile or on short peduncles receptacles, sometimes born on the ultimate 
twing, Female head are oblong ovoid receptacle, syncarpus, cylindrics. Seeds 
are separated horny endocarpus enclosed by sub-gelatinous exocarpus (1mm 
thick) oblong ellipsoid in nature. The sweet yellow sheaths around the seeds 
are about 3-5 mm thick and have a taste similar to that of pineapple, but 
milder and less juicy. Even though it is well    known for its antibacterial, anti-
inflammatory, anti-diabetic, antioxidant and immunomodulatory properties 
there are no evidences regarding the anti-hyperlipidaemic effect of the stem 
hence our study has its relevance 
The biggest organ in the body is the "LIVER" and it is likewise fills in as the 
essential metabolic organ of the body. In spite of the fact that the liver is 
comprised of various cells like hepatocytes, endothelial, kupffer and stellate 
cells are the most dominating with critical capacities. Another most essential 
one of a kind component of the liver is its capacity to recover. Well grown-up 
liver (i.e. Grown-up) is the standard organ accountable for detoxifying and 
metabolizing, exogeneous/endogenous mixes, rendering them more 
hydrophilic, which as often as possible impact their force and action1.  
Liver infections are the genuine restorative issues went up against by the 
people wherever all through the world. The epidemiological review 
demonstrates that around 20,000 passings happen reliably in light of liver 
issue. In Africa and Asia, the major driver of liver maladies are contaminations 
by infection and parasite, while in Europe and in North America, a vital reason 
is liquor manhandle. Liver ailments are primarily realized by deadly chemicals, 
over the top affirmation of ceaseless liquor, diseases and immune system 
issue. Hepatic harm by over measurements of drug appears, from every 
angle, to be a run of the mill contributing component. Liver is required to do 
physiological limits and additionally to guarantee against the perilous of 
dangerous drugs and chemicals. Prescription impelled substance damage is 
accountable for 5% of each mending focus attestation and half of all serious 
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liver disappointment. Over 75% of episodes of specific prescription reactions 
achieve liver transplantation or death2. 
 
1.2 Pathophysiological Mechanisms  
Pathophysiological components of hepatotoxicity are as yet being found and 
contain both hepatocellular/extracellular systems.  
Disturbance of hepatocyte: Medications can bound to intracellular proteins by 
covalent tying which realize a reducing in ATP levels inciting actin intrusion. 
Some portion of actin fibrils at the surface of the hepatocyte causes blebs and 
burst of the layer.  
1.3 Interruption of transport protein 
Bile stream might be hindered by meds that impact transport proteins at 
canalicular film. Loss of villous strategies and interruption of transport pumps, 
for instance, multidrug resistance-related protein 3 hinder release of bilirubin 
realizing cholestasis  
Cytolytic T-cell actuation: Co-valent binds of pharmaceutical to Cytochrom P-
450 compound goes about as an immunogen enacting T-cells and cytokines 
and energizing multifaceted safe responses.  
Apoptosis of hepatocytes: Enhancement of apoptotic pathways by tumor rot 
calculate alpha receptor of Fas may trigger the course of intercellular 
caspases, which achieve altered cell passing.  
Mitochondrial disturbance: A couple of meds limit mitochondrial limit by 
twofold effect on both beta-oxidation vitality creations by frustrating the union 
of nicotinamide adenine dinucleotide and flavin adenine dinucleotide, realizing 
decreased ATP era.  
Bile pipe damage: Dangerous metabolites discarded in bile may achieve 
mischief to bile course epithelium3. 
Solution/sedate incited liver harm is a prosperity issue, and is depended upon 
to increase as the amount of drugs being eaten up augmentations, both 
remedy and non-solution, and in view of the present example of usage of 
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pharmacologically dynamic substances in correlative and option prescription. 
Prescription/tranquilize incited hepatotoxicity is the most surely understood 
reason alluded for withdrawal of authoritatively endorsed meds from the 
business. It also speaks to more than 50 percent of occasions of serious liver 
disappointment in the United States. The positive recurrence of 
solution/medication incited liver harm is difficult to gage, and all things 
considered, concentrates going to measuring its event encounter the evil 
impacts of drawbacks, for instance, under-detailing and that data by 
expansive start from audit thinks about. Frequently, there is in like manner a 
nonattendance of information about self-arrangement and use of home grown 
item that may associate with prescription and non-doctor embraced 
medications4.  
Despite the repeat of solution actuated liver harm being low, data from the 
Centers for Disease Control and Prevention in the U.S. report pretty much 
1600 new extraordinary examples of liver disappointment yearly, of which 
Paracetamol hepatotoxicity speaks to plus or minus 41%. Exactly when taking 
a sexual orientation at hospitalized patients, the rate of hostile solution 
reactions is assessed to be 6.7%, and deadly disagreeable medicine 
reactions mean 0.32%, as controlled by a meta-investigation of around 40 
imminent reviews. Amid the period 1995 to 2005, the reports of horrible 
prescription reactions and also passings related to these, have drastically 
increased. Various examples of pharmaceutical activated liver harm are 
particular, i.e. the reaction is whimsical considering the known 
pharmacological properties of the medication, and from this time forward is 
scarcely perceptible amid preclinical periods of change. There are however 
studies to demonstrate that these reactions might be liable to an extended 
affectability of the patient to the medicine being alluded to, dependent upon 
such segments as other going with contaminations or other relating 
prescriptions. Certain innate factors, for instance, HLA-sort, can once in a 
while add to the affectability of a man to opposing pharmaceutical reactions. 
Commonly, clinically clear hostile drug reactions happen when some season 
of inertness, wherever in the compass going from one to 12 months (most by 
and large within 90 days), and about constantly vanish after departure of the 
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solution. Pharmaceutical researched liver damage may give a couple of 
unmistakable clinical segments; hepatitic/hepatocellular, cholestatic or mixed.  
Regardless of their etiology, solution/tranquilize prompted hepatotoxicity 
remains a significant issue amid medicine advancement in the pharmaceutical 
business, both concerning extended threat for patients encountering clinical 
trials, besides tolerant hazard after the acquaintance of new drug with the 
treatment. Moreover, because of the extended costs that take after 
disappointment of a prescription to-be at a late stage in medicine 
improvement or after its launch6. 
1.4 Drug Toxicity Mechanisms 
Commonplace division of pharmaceutical responses is of at the very least 2 
significant events which include:  
 Drugs which clearly impact liver.  
 Drugs which intervene a safe response.  
Characteristic/unsurprising medication responses: Drugs that has a place into 
this characterization cause reproducible injuries in creatures and mischief is 
related to measurements. Mischief can be a result of medicine itself or to its 
metabolite. Acetaminophen is the most proper delineation of a known regular 
or obvious hepatotoxin at supertherapeutic measurements. Another outline is 
carbon tetrachloride.  
Quirky/eccentric medication responses: These medication reactions can be 
portioned into those that are named excessive touchiness or immunoallergic 
and those that are metabolic-particular. It occurs without evident 
measurement reliance and in an unusual manner  
Hepatotoxicity to a great extent demonstrates the compound constrained liver 
devastation. A few drugs when devoured in overdose and once in a while 
notwithstanding when taken inside suggest measurement may harm 
numerous inner organs. Few compound/substances involving those that are 
utilized as a part of research facilities (Example: CCl4 and Paracetamol) and 
ventures (Lead, and arsenic) and characteristic mixes (microcystine and 
aflatoxins) and home grown treatments (cascara sagrada, ephedra) can 
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likewise root hepatotoxicity. Chemicals/Compounds that cause liver harm are 
as one marked as hepatotoxins.  
NSAIDS (Acetaminophen, Aspirin, Ibuprofen)  
Glucocorticoids.  
Against Tubercular medication (Isoniazid).  
Mechanical poisons (arsenic, carbon tetrachloride, vinyl chloride).  
Natural cures (Ackee organic product, camphor, cycasin, kava leaves, 
valerian, comfrey).  
1.5 Alcohol liquar Hepatotoxicity  
Liquor is one of the key inducer of end-stage liver harm far and wide. In the 
United States, alcoholic liver malady is the second most normal reason 
behind liver transplantation. The Dionysos Study, an accomplice examination 
of the transcendence of unending liver malady in an Italian people, showed 
that 21% of the masses considered was at peril for making liver harm. Of 
these, only 5.5% of the general population at peril implied at genuine liver 
harm. Around 50 years earlier it was acknowledged that liquor in itself was not 
destructive, rather that the dietary deficiencies every now and again running 
as an inseparable unit with it were the genuine purposes behind liver damage. 
Regardless, it was demonstrated by Lieber and De Carli that in rats, alcoholic 
liver harm made despite satisfactory sustenance. The lethality of liquor was 
later on exhibited to be related to its absorption framework by liquor 
dehydrogenases (ADHs) moreover to the assimilation framework by CYP2E1. 
There is also a piece of assimilation framework by catalase. The basic 
pathway for ethanol EtOH oxidation in the liver is by method for ADH to 
acetaldehyde, which is associated with the diminishment of NAD to NADH. 
NADH in this way constructs xanthine oxidase activity, which rises era of 
superoxide. Metabolic arrangement of EtOH by liquor dehydrogenase impacts 
the redox status of the liver in like manner in various ways. Lifted 
acetaldehyde creation after EtOH digestion system decreases hepatic 
glutathione (GSH) content. The reducing in GSH is both on account of an 
extended disaster, and furthermore a lower rate of blend  
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Ethanol prompts number of harmful metabolic changes in liver. Admission of 
ethanol for long time prompts to advancement of steatosis, alcoholic hepatitis 
and cirrhosis bringing about weight and volume changes. Around 80% of 
overwhelming consumers had been accounted for to create steatosis, 10-35% 
alcoholic hepatitis and roughly 10% liver cirrhosis.  
1.6 System hidden Ethanol actuated hepatotoxicity  
Liquor utilization brings about increment in arrival of endotoxin from gut 
microbes and layer porousness of gut to endotoxin or both. Females are all 
the more frequently touchy to these progressions. Blood endotoxin is lifted 
and enters liver where it is overwhelmed by Kupffer cells that get to be 
distinctly actuated discharging TNF-alpha, PGE2 and free radical. 
Prostaglandins increment oxygen take-up and are in charge of 
hypermetabolic state in liver. Increment in oxygen request prompts to hypoxia 
of liver and on reperfusion alpha - hydroxyethyl free radicals are framed that 
prompts to tissue harm in oxygen poor pericentral districts of liver lobule. 
Obstructing of these occasions should be possible by sanitization of gut 
utilizing anti-infection agents or decimation of Kupffer cells with Gdcl3 and in 
this manner averts liver injury8..  
1.7 Symptoms of Hepatotoxicity 
signs and side effects delineated in different foundations for Hepatotoxicity 
incorporate 15 side effects as recorded below: 
 Sickness                                                   Regurgitating 
 Stomach torment                                      Yellow skin 
 Loss of hunger                                          Hepatomegally 
 Looseness of the bowels                          Irregular liver capacity test                
                                                                 comes about 
 Tiredness                                                  Swelling in feet 
 Shortcoming 
 Jaundice                                                    Weight increase because  
                                                                  of water maintenance  
 Yellow eyes                                               Delayed draining time. 
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1.8 Treatment for Hepatotoxicity  
The rundown of medications specified in different hotspots for hepatotoxicity 
incorporates the accompanying. Continuously take after expert restorative 
guidance about any treatment or change in treatment arranges. Treatment of 
hepatotoxicity is relies on causative operator, level of liver brokenness and 
age and general strength of patient. Medicines for hepatotoxicity include:  
Withdrawal of causative solution or expulsion from introduction to causative 
specialist.  
General checking of patient and survey of liver capacity – where liver 
brokenness is mellow to direct and liver capacity is moving forward.  
Finish shirking of liquor and drug that may add to further liver harm.  
N-Acetylcysteine is utilized for paracetamol harmfulness.  
Administration of indications of liver harm.  
 Nutrition – with vitamin supplementation as required  
 Regular practice with a specific end goal to keep up bulk.  
 Ursodeoxycholic corrosive.  
Administration of pruritus  
 Cholestyramine  
 Antihistamines.  
Administration of ascites  
 Low sodium eat less carbs.  
 Diuretics – furosemide, spironolactone.  
 Removal of liquid through a needle in the stomach area – 
Paracentesis.  
 Portosystemic shunting.  
Administration of entry hypertension  
 Beta – blockers  
 Oesophageal variceal banding  
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 Portocaval shunt  
 Administration of intense liver disappointment because of 
hepatotoxicity  
 Supportive care dependably in emergency unit aviation route 
assurance, liquid and electrolyte administration.  
 Management of intricacies, for example, draining issues and hepatic 
encephalopathy.  
 Liver transplantation – for intense fulminant liver disappointment or end 
organize cirrhosis. 
1.9 Present day Medicines for Treatment of Liver Diseases  
Liver illnesses can be dealt with utilizing allopathic and in addition by utilizing 
home grown medications.  
1.10 Hepatoprotective Allopathic Treatment  
Couple of present day drugs are accessible for treating liver illnesses that 
incorporates:  
Ursodeoxycholic corrosive (Ursodiol): Ursodiol diminishes intestinal retention 
and stifles hepatic union and capacity of cholesterol. It is predominantly 
utilized as a part of administration of constant hepatic ailments in people.  
Penicillamine: Penicillamine chelates a few metals like copper, iron, lead and 
mercury shaping stable water dissolvable edifices which are renally 
discharged.  
1.11 Different medications: Antiviral pharmaceutical, for example, alpha 
interferon, ribavirin, steroids, anti-infection agents and so on are additionally 
utilized as a part of liver ailments. Drugs like tricholinecitrate, 
trithioparamethoxy phenyl propane, basic phospholipids, blend of 
medications, for example, L-ornithine, L-aspartate and pancreatin, silymarin 
and Ursodeoxycholic corrosive are generally recommended for hepatitis, 
cirrhosis and other liver sicknesses. N-acetylcysteine is utilized as a part of 
early periods of acetaminophen harmfulness. L-carnitine is conceivably 
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significant amid valproate poisonous quality. Cholestyramine can be utilized to 
mitigate pruritus.  
1.12 Inconveniences of allopathic medications  
Symptoms of numerous cutting edge medications are generally disturbing. 
Collaborations, contra-cooperations, reactions and danger of engineered 
pharmaceutical shift from gentle to extreme that incorporates sleep 
deprivation, regurgitating, weariness, dry mouth, looseness of the bowels, 
blockage, tipsiness, self-destructive thought, despondency, seizures, pallor, 
male pattern baldness, high glucose, swelling, impotency, perplexity, blacking 
out lastly passing. Anti-microbials more often than not bring about stomach 
furious or unfavorably susceptible responses. Interferon indicates symptoms 
as influenza like ailment with fever and body throbs.  
1.13 Natural Hepatoprotective Drug Treatment  
Various polyherbal arrangements have been utilized as a part of treating 
different liver issue since ages. Some natural definitions include:  
1.14 Constraints of natural arrangements  
Natural based arrangements for treating liver issue has been utilized as a part 
of India for long time and has been promoted worldwide by selling 
pharmaceuticals. Regardless of prevalence of home grown prescriptions for 
liver illnesses specifically, are still inadmissible treatment modalities for liver 
sicknesses. Constraining variables include:  
 Lack of institutionalization systems of home grown arrangements.  
 Lack of recognizable proof of dynamic parts and standards.  
 Lack of randomized controlled clinical trials (RCTs).  
 Lack of toxicological evaluation67.  
 Poor solvency.  
 Poor bioavailability.  
 Poor hepatic cell recovery.  
1.15 Hepatoprotective Mono-Herbal Medicines  
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Restorative plants are critical wellsprings of hepatoprotective medications. 
Very nearly 160 phytoconstituents from 101plants have been guaranteed by 
Pharmacopeia Foundation to have hepatoprotective action11. Home grown 
medications are most generally utilized than allopathic medications as 
hepatoprotectives in light of the fact that these are normally cheap, better 
social adequacy, enhanced similarity with human body and insignificant 
symptoms. Different classes of phytoconstituents like flavonoids, triterpenes, 
lignans, steroids, glycosides, polyphenols, saponins, coumarins and 
unpredictable oils and so forth gangs hepatoprotective action. 
Basically diabetes is characterized by hyperglycemia, a condition of lack of 
insulin and development of complications in nephrons of kidney, peripheral 
nerves and retinal damages. Considerable effect on heart has also be the 
problem of developing further complications leading to atherosclerotic threats 
to brain, myocardium and lower extremities. Hyperglycemia causes various 
kind of injury to vascular system viz, increased pace of high glucose flux, 
intracellular production of advanced glycation products, activation of protein 
kinase and abnormal hexoseamine pathway. The increased mitochondrial 
reactive oxygen species (ROS) would lead to microvascular changes heart 
and other vital functions of organs and their complex pathways . The damage 
breaks out by ROS production both mitochondrial and non-mitochondrial 
results in, tumor formation, age-related degeneration, inflammatory conditions 
and diabetes mellitus [.  Better understanding of ROS production and its 
intervention strategies leading to solution to this problem with newer 
technologies. In this context major factor for onset of diabetes has been 
evidenced due to ROS generation . Further various animal studies confirm 
that embryos are more vulnerable to the oxidative stress especially in type 2 
diabetes. Maternal abnormalities were developed and observed to be more 
prominent in heart and reduction in pregnancy of the animals has been 
notified .The existing methods of treating diabetes do not combat diabetic 
complications, so there is an increased need for effective treatment, which is 
essential to fight with diabetic complications in relation to considerable 
reduction of ROS by using various technology and herbal drugs. 
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1.16 Consequences for Insulin Resistance and ROS production 
In a condition pertaining to the high plasma levels of glucose and free fatty 
acids leads to increased production of reactive oxygen species (ROS) and to 
a least of reactive nitrogen species (RNS). In turn the initiation of various 
kinases starts occurring; proceed to phosphorylation of the insulin receptor 
and nitric oxide generation . Both the aforementioned pathways cause the 
signaling of insulin and suppress it drastically. Cascading reactions lends 
increased insulin resistance in liver, skeletal muscle and adipose tissues.As 
shown in the Fig 1.  
Increased free fatty acid level and lipid content are the prime factor for insulin   
resistant type 2 diabetes. Besides, the production of ROS could be more due 
to free fatty acids are common and mitochondrially how ROS is produced is 
still not understood and yet to be explored. 
1.17 ROS and associated Hypertension 
The considerate onset of hypertension is due to the non-phagocytic NAD(P)H 
oxidase (Nox1, Nox 2 and Nox 4), apart from other factors for increased 
diabetic and hypertensive complications such as mitochondrial generation, 
inflammation, hypertrophy apoptosis, fibrosis, angiogenesis and rarefaction. 
Miscellaneous occurrence for ROS bounds to xanthine oxidase, 
cyclooxygenase, lipoxygenase and nitric oxide synthase. As shown in the Fig 
2. 
Normal physiological processes affected by ROS are immunity, endocrine 
functions, embryogenesis and signal transduction at cellular level [13]. The 
intervention has given a tool to effectively control the ROS generation by 
antioxidants or nitric oxide production, to minimize the vascular injury, renal 
dysfunction and prevent target organ damage in diabetes and hypertension
   
1.18 Delayed Wound Healing Pattern – Increased ROS 
Scoring up of ROS generation would lead to delayed wound healing, as it is 
the significant clinical problem to deal with to treat with different approach. 
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Antioxidants have forecasted evidence for healing process to be very effective 
if it is provided. a study has provided robust substantiation in cultured 
fibroblast, a diabetic phenotype and IGF1, which promotes wound healing on 
exposure to antioxidants. Pre-treatment of antioxidants increased the IGF1 
has brought down diabetic complication and accelerate wound healing .      
 
 
1.19 Basis for Diabetic and ROS  
Long term diabetic causes are 
i. Excess nourishment (Food) 
ii. sedentary life style 
iii. genetic or miscellaneous factors 
All the above conditions leads to glucose and fatty acid overload, in addition 
the reaction of glucose with plasma proteins forms glycation end products and 
ROS. The ROS which in turn causes increased non-availability of nitric oxide, 
increased inflammatory mediators and modification of lipoproteins in 
atherosclerotic condition. 
Common complications of diabetes due to ROS are 
i. development of insulin resistance 
ii. β- cell dysfunction 
iii. type 2 diabetes 
iv. increased glucose tolerance 
1.20 Diabetic Nephropathy and ROS 
ROS play an important role in commencement and progression of diabetic 
nephropathy. The roles of oxidative stress in pathogenesis of diabetes 
complications are evidenced. Vulnerability to glomeruli and retina is observed 
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in patients with insulin resistance diabetes. A ROS-regulated signaling 
pathway leads to extracellular matrix (ECM) deposition in diabetic kidney was 
evidenced. ROS are increased in the glomeruli isolated from streptozotocin 
diabetic rats, providing a direct evidence of increased ROS in diabetic 
glomeruli. 
An approach positively controls the nephritic damages are the treatment with 
antioxidants. As Antioxidants effectively inhibit high glucose and H2O2 induced 
activation in case of diabetic nephropathy, which would favor patients. The 
effect of antioxidant therapy is well documented in cell and animal studies, 
although convincing evidence for clinical efficacy is still lacking. 
Exhaustive glycemic control and inhibition of angiotensin II delay the onset 
and progression of diabetic nephropathy, in part, through prevention of 
overproduction of ROS. Antioxidants have been shown to prevent or delay the 
onset of diabetic nephropathy and its progression. 
1.21 Role of ROS in insulin resistant type 2 diabetes 
Receptor level binding of insulin at cell surface leads to the phosphorylation 
and various signaling pathways, which has been affected by ROS with 
increased insulin resistance and pancreatic cell dysfunction. Therapy with 
antioxidants like N-acetyl-L-cystine and taurine prevents the hyperglycemia 
induced by insulin resistance. In patients with type 2 diabetes, acute and 
chronic administration of lipoic acid, antioxidant, improved insulin resistance.  
1.22 Role of Herbal antioxidants in ROS 
The damaging effects of ROS is tackled effectively by antioxidants, normally 
superoxide and hydrogen peroxide are produced in the body. If excess 
quantities of generation leads to pathological ROS production. Many herbs 
has the potential to compromise ROS such as green tea, grape seed, ginseng 
and Scutellaria baicalensis. Long while herbal medicines used for the 
diabetes has been in existence. Current pre-clinical and clinical studies have 
demonstrated that many of them exhibit potent anti- inflammatory and anti-
oxidative properties, and have also identified the active phytochemicals 
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responsible for their activities. The herbal medicines and nutraceuticals, as 
well as their bioactive components, which exhibit anti-inflammatory and anti-
oxidative properties, provide a promising approach for the prevention and 
treatment of diabetic complications. The etiology of diabetes and its 
complications are because of free radicals and for the reason herbs with 
antioxidant properties are believed to possess faith in controlling and 
minimizing the damage due the reactions. The list of some herbs used for 
diabetes and its complications are given in Nearly 400 herbs are accounting 
for diabetes treatment worldwide. 
 Acacia arabica (Babhul) has got anti-diabetic agent shown to have 
hypoglycemic effect. Aegle marmelos (Bengal Quince) which improves 
digestion and reduces blood glucose, urea and serum cholesterol level. Allium 
cepa (Onion) is a potential antioxidant, anti hyperglycemic and anti 
hyperlipedemic activity. Allium sativum (Garlic) has been used to increases 
insulin secretion and controls lipid peroxidation. Aloe vera stimulates β cell to 
secrete insulin, Anti-inflammatory and wound healing. Azadirachta indica 
(Neem) evidenced using anti-hyperglycemic, hepatoprotective and antioxidant 
activities. Eugenia jambolana (Jamun) is a viable anti-hyperglycemic agent. 
Mangifera indica (Mango) is a anti-diabetic agent, reduces intestinal glucose 
uptake. Momordica charantia (Bitter gourd) is utilized as antidiabetic and 
antihyperglycemic Agent. Ocimum Sanctum (Holy basil) cause glucose level 
decline in fasting condition, triglyceride and total lipid content. Phyllanthus 
amarus (Bhuiawala) is a antinflammatory, anticancer, antioxidant and 
antidiarrhoeal. Certain formulations available for the diabetic treatments are 
given table 2 
Bao H et al studied icariin a flavonoid of Epimedium pubescens known to 
have considerable antioxidant activity . They demonstrated cardiac functions 
and mitochondrial oxidative stress in streptomycin induced diabetic rats. The 
observations are in favor of controlling oxidative stress of cardiac 
complications in diabetes induced animal. An 8 weeks of administration 
markedly improved cardiac function and ROS has been proved effectively. 
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The nanotechnology is facing expansions in all dimensions for serving 
mankind, that almost all the countries are striving to explore for the social well 
being and economy of the country. Nanoparticles are known to have 
tremendous applications in the field of diagnosis and theraphy. Such 
imperative nanoparticles have very great trait to carry and serve like an 
antioxidant, antihyperglycemic and ROS interfering action. Treatment of 
antidiabetic potent nanoparticle with plants would have therapeutic value do 
create a new platform for herbal medicines in nanoscience for drug delivery. 
Intentions of few antidiabetic nanoparticles of herbal origin are discussed. the 
options for herbal nanotechnology is shown in the fig 3. 
Feng lin et al have demonstrated the preparation of nanosuspension of 
Cuscuta chinensis, since its principles are majorly flavonoids which has got 
poor solubility. It drives them to make it more soluble formulation. The 
prepared formulations are tested with acetaminophen induced hepatotoxic 
rats. As the flavonoids are known to have antioxidant which has the caliber to 
control oxidative stress these components (flavonoids) are taken into account 
in this study. They observed only 50mg/kg of body weight of nanosuspension 
containing Cuscuta chinensis, effective than 125mg/kg weight administered 
from ethanolic extract of same drug. In this context suggestions are given to 
increase the tough molecules solubility enhancement through nanotechnology  
1.23 High antioxidant activity of Dalbergia sissoo (Indian Rosewood) 
Nayan Roy et al studied extracts of the plant stem bark, they intervened to 
extend they work towards invitro antioxidant determination by chemical 
method, using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging 
activity. In their experimentation of aqueous and methanolic extract they found 
aqueous extact has greater activity. They concluded that plant has high 
antioxidant activity and it may find it very useful in the treatment of diseases 
and complications caused by oxidative stress. 
1.24 Nanoencapsulation of Albizia chinensis 
Avnesh kumar et al explained the nanoencapsulation of the herb having 
potential antioxidant activity of its content quercitrin. The polymer poly-D,L-
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lactide (PLA) is used to encapsulate the material and solvent evaporation 
technique was deployed to prepare the nanodimensions of the drug. The drug 
quercitin was made to encapsulate to increase the solubility, permeability and 
stability of the molecule. Moreover, the properties of nanomedcine has 
provided a new potential use of less useful highly active antioxidant molecule 
towards the development of  oxidative stress related inflammation and its 
related complication profiles.  
 
 
1.25 Antioxidant enriched Siylmarin Nanoparticles 
Xia cao et al ventured in developing the porous silica nanoparticles of 
silymarin to increase the solubility as it has the considerable antioxidant 
activity. The silymarin nanoparitcles were prepared by porous microemulsion 
and ultrasonic corrosion methods. The results are bioavailability of silymarin 
was considerably increased despite the drugs basic poor solubility nature. 
The evidences are strong that herbal components are appropriate option for 
oxidative stress management in excessive ROS generation. 
1.26 Metal andioxidant nanoparticle  
As antioxidants have significant role in influencing ROS, such antioxidant 
nanoparticles are prepared from metals such as gold, silver and so on. These 
methods of producing metal antioxidant nanoparticle using plant extracts are 
extremely biosynthesized. Kannan et al explored syhthesis of gold 
nanoparticles using leaf extracts of Coleus amboinicus. The prepared 
nanoparticles are characterized by UV-vis spectroscopy, XRD, TEM and 
SAED analyses. This method utilizes cheap production of nanoparticles with 
non toxic nature. Praveenkumar et al studied gold nanoparticle synthesis 
using Zingiber officinale extract. They got nanoparticles of size range 5 to 15 
nm, and Zingiber officinale as stabilizing and reducing agent which is more 
potent than asprin. Characterization was done by Dynamic Light scattering 
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(DLS), TEM and UV-Vis Spectroscopy. The produced nanopartcles are 
biocompatible with the blood has been observed [35]. 
Diabetic treatment channelizing to the effective control of glucose level and 
specific strategy to target the ROS generating pathway curbing, do produce 
better results and compliments each other beneficially. A biological 
antioxidants capable of restraining oxidative stress mediated diabetic 
complication in due course of hyperglycemia is still mandatory to foresee 
better clinical improvements. The antioxidant enriched herbal components is 
the viable tool to cope with oxidative stress condition in diseased condition 
especially, the diabetes. Secondly, evidences are there that such components 
of antioxidant, antidiabetic and hypoglycemic herbs are tailored to 
nanotization for the maximum benefit. Provided with the strong scientific back 
up evidences, the clinical implications of nanotechnology based herbal 
constituents such as antioxidants are in great need to the mankind, to fight 
with oxidative stress related complications in diabetes and related ailments. 
 
      Table No 1: List of some herbs for diabetes and its complications 
 
Botanical name Common/Vernacular 
Name 
Eugenia Jambolana Indian Gooseberry 
Momordica charantia Bitter gourd 
Ocimum sanctum Holy Basil 
Phyllanthus amarus Bhuiawala 
Pterocarpus marsupium benga 
Tinospora cordifolia Guduchi 
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Trigonella foenum Fenu greek 
Withania somnifera Ashwagandha 
Allium sativum Garlic 
 
 
 
 
 
 
                         Table No 2: List of herbs and its intention to intend 
Name of Herb Common/Vernacular Intention/purpose 
Acacia arabica Babhul Anti-diabetic agent 
shown to have 
hypoglycemic 
effect. 
Aegle marmelos Bengal Quince Improves digestion 
and reduces blood 
glucose, urea and 
serum cholesterol 
level 
Allium cepa Onion Antioxidant, anti 
hyperglycemic and 
anti 
hyperlipedemic 
activity 
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Allium sativum Garlic Increases insulin 
secretion and 
controls lipid 
peroxidation 
Aloe vera Kathalai Stimulates β cell to 
secrete insulin, 
Anti-inflammatory 
and wound healing  
Azadirachta indica Neem Anti-
hyperglycemic, 
hepatoprotective 
and antioxidant 
activity 
Eugenia jambolana Jamun Anti-
hyperglycemic 
Mangifera indica Mango Anti-diabetic 
agent, reduces 
intestinal glucose 
uptake. 
Momordica charantia Bitter gourd Antidiabetic and 
Antihyperglycemic 
Agent 
Ocimum Sanctum Holy basil Glucose level 
decline in fasting 
condition, 
triglyceride and 
total lipid content 
Phyllanthus amarus Bhuiawala Antiinflammatory, 
anticancer, 
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antioxidant and 
antidiarrhoeal  
 
Jackfruit (Artocarpus heterophyllus) is one of the most significant trees in 
tropical homegardens and perhaps the most widespread and useful tree in the 
important genus Artocarpus. It is a medium-size evergreen tree typically 
reaching 8–25 m (26–82 ft) in height that is easily recognized by its fruit, the 
largest among cultivated plants. The succulent, aromatic, and flavorful fruit is 
eaten fresh or preserved in myriad ways. The nutritious seeds are boiled or 
roasted and eaten like chestnuts, added to flour for baking, or cooked in 
dishes. It is also known for its remarkable, durable timber, which ages to an 
orange or red-brown color. The leaves and fruit waste provide valuable fodder 
for cattle, pigs, and goats. Many parts of the plant including 
the bark, roots, leaves, and fruit are attributed with medicinal properties. 
Wood chips yield a dye used to give the famous orange-red color to the robes 
of Buddhist priests. The tree can provide many environmental services. It is 
highly wind tolerant and therefore makes a good component in a windbreak or 
border planting. Growing in pastures, it can provide fallen fruit for livestock, 
shade, and long-term timber. In homegardens, the dense jackfruit canopy can 
provide a visual screen and is very ornamental. Introduced to most Pacific 
islands after European contact, the tree can be found throughout the Pacific, 
mainly in homegardens, where it finds a place among other favorite 
multipurpose plants. It is easy to grow and more adaptable than some of the 
other common Artocarpus species such as breadfruit (A. altilis). It is not 
considered to be an invasive species. 
1.27 Distribution 
1.27.1 Native range 
The tree is reportedly native to the rainforests of Malaysia and the Western 
Ghats of India. 
1.27.2 Current distribution 
Jackfruit has been cultivated since prehistoric times and has naturalized in 
many parts of the tropics, particularly in Southeast Asia, where it is today an 
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important crop of India, Burma, China, Sri Lanka, Malaysia, Indonesia, 
Thailand, and the Philippines. It is also grown in parts of 
Africa, Brazil, Suriname, the Caribbean, Florida, and Australia. It has been 
introduced to many Pacific islands since post-European contact and is of 
particular importance in Fiji, where there is a large population of Indian 
descent. In a 1985 survey, jackfruit was present on 10–24% of Indo- 
Fijian sugarcane farms in western Viti Levu, Fiji (Thaman and Ali 1993). In 
comparison, mango (Mangifera indica), papaya (Carica papaya), drumstick 
tree (Moringa oleifera), Murraya koenigii, and tamarind (Tamarindus indica) 
were found on 75–100% of the farms. In Hawai‘i, it is occasionally found in 
homegardens, and it is sold in farmer’s markets, although commercial 
production is minor. Jackfruit is occasionally planted in backyard gardens in 
Guam. The species is also reported to have been introduced to Palau, Yap, 
Pohnpei, Nauru, Tabiteuea in Kiribati, Samoa, and other islands (Fosberg et 
al. 1979). 
1.28 Botanical Description 
1.28.1 Preferred scientific name 
Artocarpus heterophyllus Lam. 
1.28.2 Family 
Moraceae (mulberry family) 
1.28.3 Non-preferred scientific names 
Artocarpus brasiliensis Gomez 
Artocarpus heterophylla Lam. 
Artocarpus maxima Blanco 
Artocarpus philippinensis Lam. 
Polyphema jaca Lour. 
Soccus arboreus major Rumph. 
Artocarpus integer (Thunb.) Merr and its synonym A. integrifolia L. f. are a 
different species (champedak), and these names have often mistakenly been 
used as synonyms for A. heterophyllus. 
1.28.3 Common names 
Pacific islands dapanapan(?) (Yap) 
jack, jack tree, jackfruit, jak, jakfruit (English) jacquier (French) 
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kapiak (Papua New Guinea) 
uto ni India (Fiji) 
‘ulu initia (Samoa) 
Other regions 
banun, khanun, makmi (Thai) 
buen pan, jaca, pan de fruta, rima (Spanish) 
chakki, kanthal, kathal, kathar, panos (Hindi) 
Jackfrutchbaum (German) 
langka, nancas (Filipino) 
nangka, nongko (Javanese) 
Species Profiles for Pacific Island Agroforestry (www.traditionaltree.org) 
 
 
1.28.4 Size and form 
Jackfruit is a medium-size, evergreen tree that typically attains a height of 8–
25 m (26–82 ft) and a stem diameter of 30–80 cm (12–32 in). The canopy 
shape is usually conical or pyramidal in young trees and becomes spreading 
and domed in older trees. The canopy diameter at 5 years old 
ranges from 3.5–6.7 m (11–22 ft) and can reach 10 m or more in older trees. 
The tree casts a very dense shade. Heavy side branching usually begins near 
the ground. All parts of the tree exude a sticky white latex when injured. 
1.28.5 Flowers 
This species is monoecious, having male and female inflorescences (or 
“spikes”) on the same tree. Male and female spikes are borne separately on 
short, stout stems that sprout from older branches and the trunk. Male spikes 
are found on younger branches above female spikes. Male spikes are dense, 
fleshy, cylindrical to club-shaped, and up to 10 cm (4 in) in length. Flowers are 
tiny, pale green when young, turning darker with age. Female flowers are 
larger, elliptic or rounded, with a tubular calyx. The flowers are reportedly 
pollinated by insects and wind, with a high percentage of cross-pollination. 
1.28.6 Leaves 
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Leaves are dark green, alternate, entire, simple, glossy, leathery, stiff, large 
(up to 16 cm [6 in] in length), and elliptic to oval in form. Leaves are often 
deeply lobed when juvenile and on young shoots. 
1.28.7 Fruit 
Jackfruit has a compound or multiple fruit (syncarp) with a green to yellow-
brown exterior rind that is composed of hexagonal, bluntly conical carpel 
apices that cover a thick, rubbery, whitish to yellowish wall. The acid to 
sweetish (when ripe) banana-flavored flesh (aril) surrounds each seed. The 
heavy fruit is held together by a central fibrous core. Fruits are oblong-
cylindric in shape, typically 30–40 
1.28.8 Left: Female (top) and male (bottom) flower spikes. Right: 
Seedlings have lobed leaves compared to the entire leaves on mature 
trees. photos: C. Elevitch Acrocarpus heterophyllus (jackfruit) cm (12–16 in) 
in length but sometimes up to 90 cm (35 in). They usually weigh 4.5–30 kg 
(10–66 lb), although a weight of 50 kg (110 lb) has been reported (Morton 
1987). The heavy fruit is borne primarily on the trunk and interior part of main 
branches. Fruits take 90–180 days to reach maturity. In the Northern 
Hemisphere, the main bearing season is late spring to early fall (between 
March and September). A few fruits mature in winter or early spring. 
1.28.9 Seeds 
Seeds are light brown to brown, rounded, 2–3 cm (0.8–1.2 in) in length by 1–
1.5 cm (0.4–0.6 in) in diameter, and enclosed in a thin, whitish membrane. Up 
to 500 seeds can be found in each fruit. Seeds are recalcitrant and can be 
stored up to a month in cool, humid conditions. 
1.28.10 Rooting habit 
Jackfruit has a strong taproot. 
1.28.11 Similar species 
Champedak (Artocarpus integer [Thunb.] Merr.) is easily mistaken for 
jackfruit. There are several indicators differentiating the two species; perhaps 
the easiest to see is that champedak has smaller, rounder fruits, with less 
latex and thicker rind. However, champedak is rarely found in the Pacific. 
 
Hyperlipidaemia mainly increased level of cholesterol or low-density 
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lipoprotein cholesterol (LDL-C) contributes significantly to the manifestation 
and development of atherosclerosis and coronary heart diseases (CHDs). 
Cardiovascular diseases, including atherosclerosis, are the most common 
causes of mortality and morbidity worldwide. Approximately 12 million people 
reportedly die of cardiovascular disease each year worldwide. Although 
several factors such as diet high in saturated fats and cholesterol, age, family 
history, hypertension, and lifestyle play a significant role in causing heart 
failure, the high level of cholesterol, particularly LDL-C is mainly responsible 
for the onset of CHDs. The lowering of lipids and cholesterol levels by drug or 
dietary interventions could reduce the risk of CHDs. The known lipid-lowering 
drugs (fibrates, statins, bile acid sequestrants, etc.) regulate the lipid 
metabolism by different mechanisms, but they also have many side 
effects.Therefore, the development of lipid-lowering drugs from natural 
sources is the best option and is in great demand. Medicinal plants continue 
to provide valuable therapeutic agents, both in modern medicine and in 
traditional systems. 
 
Plants and many plant derived preparations have long been used as 
traditional remedies and in folklore medicine for the treatment of 
hyperlipidaemias in many parts of the world. There are many plants and their 
products that have been reputedly and repeatedly used in Indian traditional 
system of medicine. Recently, the search for appropriate antihyperlipidemic 
agents have been again focused on plants because of less toxicity, easy 
availability and easy absorption in the body that may be better treatment than 
currently used drugs. Plants that were once considered of no value are now 
being investigated, evaluated and developed in to drugs with no side effects. 
One of such plant is S. hispida.Linn commonly known as ‘Shaggi button weed’ 
belongs to the family Rubiaceae and is widely distributed throughout the world 
as a useful medicinal plant . The seeds of plants as confection are cooling 
demulcent and given in diarrhea and dysentery. Seeds have been 
recommended as a substitute for coffee. Seeds are crushed in to paste and 
taken orally to treat stomach problems. According to some studies, S. 
hispida.Linn has also anti hypertensive activity. The plant has been 
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extensively studied for its phytochemical composition and a large number of 
active ingredients such as, Borreline, β-sitosterol, Ursolic acid and 
Isorhmnatin. Recently, pharmacological studies have shown that S. hispida 
seeds exhibit antidiabetic properties in rats. Hence, in the present study, the 
ethanolic extract of S. hispida seeds was investigated for Antihyperlipidaemic 
activity in triton WR-1339 induced hyperlipidaemic rats. 
 
 
 
 
 
 
 
CHAPTER II 
2. LITERATURE REVIEW 
S. Chackrewarthy et al.(2002)22, in his study investigates the hypoglycemic 
and hypolipidemic effects of an ethylacetate (EA) fraction of the mature leaves 
of A. heterophyllus in a streptozotocin (STZ) induced diabetic rat model. In 
normoglycemic rats, administration of a single dose (20 mg/kg) of the EA 
fraction resulted in a significant (P < 0.05) reduction in the fasting blood 
glucose concentration and a significant improvement in glucose tolerance (P < 
0.05), compared to the controls. In STZ-induced diabetic rats, chronic 
administration of the EA fraction of A. heterophyllus leaves daily for 5 weeks 
resulted in a significant lowering of serum glucose, cholesterol and triglyceride 
(TG) levels. Compared to control diabetic rats, the extract-treated rats had 
39% less serum glucose, 23% lower serum total cholesterol and 40% lower 
serum TG levels and 11% higher body weight at the end of the fifth week. 
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Haidy S. Omar et al.,(2013)22 examined the antioxidative, hypoglycemic, and 
hypolipidemic activities of Artocarpusheterophyllus (jack fruit) leaf extracts. 
Various extracts like 70% ethanol n-butanol, water, chloroform, and ethyl 
acetate extracts are examined. The administration of 70% ethanol extract or 
n-butanol extract to streptozotocin (STZ)-diabetic rats significantly reduced 
fasting blood glucose (FBG) from 200 to 56 and 79 mg%, respectively; 
elevated insulin from 10.8 to 19.5 and 15.1 µU/ml, respectively; decreased 
lipid peroxides from 7.3 to 5.4 and 5.9 nmol/ml, respectively; decreased 
%glycosylated hemoglobin A1C (%HbA1C) from 6.8 to 4.5 and 5.0%, 
respectively; and increased total protein content from 2.5 to 6.3 and 5.7 mg%, 
respectively. Triglycerides (TG), total cholesterol (TC), low-density lipoprotein 
cholesterol (LDL-C), VLDL-C, and LDL/HDL ratio significantly declined by -37, 
-19, -23, -37, and -39%, respectively, in the case of 70% ethanol extract; and 
by -31, -14, -17, -31, and -25%, respectively, in the case of n-butanol extract; 
as compared to diabetic rats. HDL-C increased by +37% (70% ethanol 
extract) and by +11% (n-butanol extract). Both JFEE and JFBE have shown 
appreciable results in decreasing FBG, lipid peroxides, %HbA1C, TC, LDL-C, 
and TG levels, and increasing insulin, HDL-C, and protein content. 
Venkateswarulu .M et al.,(2007)22 in his study used aqueous extract from 
Artocarpusheterophyllus leaves to evaluated for its hypocholesterolaemic and 
hypotriglyceridemic activities. The animals were divided into Normal (CG), 
Triton treated group (T), Triton plus Atorvastatin, Triton plus herb extract 200 
mg/kg, Triton plus herb extract 400 mg/kg, treated groups. Oral administration 
of Artocarpusheterophyllus leaf extract (200 mg/kg and 400 mg/kg) in both 
groups At 24 hrs after treatment with TRITON WR 1339 caused a significant 
decrease in serum lipid parameters like Triglycerides (TG), Cholesterol (CH), 
LDL- cholesterol, Atherogenic index (AI), LDL/HDL Ratio and Total proteins 
as like in atorvastatin treated groups. The both extract treated groups and 
atorvastatin treated group bought about a significant increase in HDL-
Cholesterol levels levels. 
K Periyanayagam et al.,(2012)23 studied the wound healing activity of the 
leaves of artocarpusheterophyllus lam. (moraceae) on ex-vivo porcine skin 
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wound healing model and found that  that the ethyl acetate extract of the 
leaves possesses potential wound healing activity. 
P. Sivagnanasundaram et al.,(2010)22 investigated and evaluated the 
antimicrobial and phytochemical properties of Artocarpusheterophyllus in leaf 
and stem bark extracts Hexane, dichloromethane and ethanol were used as 
extraction solvents and test organisms were Escherichia coli, Micrococcus 
luteus, Aspergillusniger and Trichoderma sp. A disc diffusion test was 
adopted to test the susceptibility of the selected microbes to the extracts while 
Minimum inhibitory concentration (MIC) was determined using serial dilution 
of extracts. Ethanolic stem bark extracts (30mg/ml) of A.heterophyllusexibits 
significant antibacterial activity against Escherichia coli with 9.50 ± 0.44 
inhibition zone radii. Dichloromethane extracts of leaf and stem bark showed 
lesser antibacterial activity against both of the bacteria with inhibition zones of 
3.00 ± 0.34 mm to 5.66 ± 0.16 mm while hexane extracts did not show any 
antibacterial activity. Antifungal activity on the other hand was not detected in 
any of the extracts. Phytochemical screening confirmed the presence of 
phytosterols, anthraquinone, terpenoids, phenols, glycosides, flavonoids and 
diterpenes. 
E. R. Suchithra et al.,(2006)22 in his study “Antidiabetic activity of 
Artocarpusheterophyllus rag extract studied in high fat fed- low dose STZ 
induced experimental type 2 diabetic rats” reports that 
Artocarpusheterophyllus rag possess antibacterial, anti-inflammatory, 
antioxidant and immunomodulatory properties. In the study Diabetic rats were 
treated with Artocarpusheterophyllus rag extract at a dosage of 300 mg/kg 
b.w daily for 30 days. Metformin (200 mg/kg. b.w) was used as a reference 
drug and fasting blood glucose, plasma insulin and HbA1c were the 
parameters under consideration. The extract supplementation attenuated the 
elevated levels of glucose, glycosylated hemoglobin, AST, ALT and ALP. The 
insulin level was improved with an improvement in hepatic glycogen content 
of insulin resistant diabetic rats. The altered activities of glycogen 
metabolizing enzymes were normalized upon extract treatment. Also the 
extract improves insulin sensitivity which is evident from intraperitoneal insulin 
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tolerance test. The results show that the rags of Artocarpusheterophyllus is 
non-toxic and possess significant antidiabetic properties. 
Praveen et al.,(2007)22 herbal remedies have evolved with enormous 
impending of alleviate. Herbal medicine progress against the non-
communicable disease like diabetes is one of the propel area of research in 
the field of worldwide medicine. Hyperlipidemia is a disorder of lipid 
metabolism manifested by increase of plasma concentrations of the 
assortment of lipid and lipoprotein fractions. Hyperlipidemia has been one of 
the maximum risk factors contributing to the occurrence and relentlessness of 
coronary heart diseases. HMG Co A reductase is a key enzyme involving in 
rate limiting step of cholesterol biosynthesis. Conservative anti-hyperlipidemic 
drugs have restricted efficacies and vital side effects, so that alternative lipid 
lowering agents are required. This review explains the plants possessing 
significant anti-hyperlipidemic activity with their botanical name, family, part 
used, extract used and inducing agent of hyperlipidemia 
 
 
Sivaganasundaram et al.,(2008)23 Increasing drug resistance of pathogens 
and negative consequences of antibiotic usage has led to the search for 
alternative medicines from nature. Many plants have been exploited to cure 
infectious diseases from time immemorial. The present investigation 
evaluated the antimicrobial and phytochemical properties of Artocarpus 
heterophyllus i.e. Jack fruit (Kos in Sinhala) and Artocarpus altilis i.e. Bread 
fruit (Dhel in Sinhala) leaf and stem bark extracts. Hexane, dichloromethane 
and ethanol were used as extraction solvents and test organisms were 
Escherichia coli, Micrococcus luteus, Aspergillus niger and Trichoderma sp. A 
disc diffusion test was adopted to test the susceptibility of the selected 
microbes to the extracts while Minimum inhibitory concentration (MIC) was 
determined using serial dilution of extracts. Phytochemical screening was 
carried out by specific chemical identification tests. Bioassay data were 
statistically analyzed using two-way ANOVA (SPSS 20 at 95% confidence 
level). Ethanolic stem bark extracts (30mg/ml) of A.heterophyllus and A.altilis 
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possessed significant antibacterial activity against Escherichia coli with 9.50 ± 
0.44 mm and 7.49 ± 0.28 mm inhibition zone radii respectively. 
Dichloromethane extracts of leaf and stem bark showed lesser antibacterial 
activity against both of the bacteria with inhibition zones of 3.00 ± 0.34 mm to 
5.66 ± 0.16 mm while hexane extracts did not show any antibacterial activity. 
Antifungal activity on the other hand was not detected in any of the extracts. 
Bacterial antibiotic tetracycline and fungal antibiotic ketoconazole which were 
used as positive controls were more effective even at 1/10 concentration 
compared to all the plant extracts tested. Phytochemical screening confirmed 
the presence of phytosterols, anthraquinone, terpenoids, phenols, glycosides, 
flavonoids and diterpenes in both of the trees. These results confirm the 
potential antibacterial activity of A.heterophyllus and A.altilis 
Haidy et al.,(2005)22 The present study examines the antioxidative, 
hypoglycemic, and hypolipidemicactivities of Artocarpus heterophyllus (jack 
fruit) leaf extracts (JFEs). The 70% ethanol (JFEE), n-butanol (JFBE), water 
(JFWE), chloroform (JFCE), and ethyl acetate (JFEAE) extracts were 
obtained. Both JFEE and JFBE markedly scavenge 
diphenylpicrylhydrazylradical and chelate Fe+2 in vitro. A compound was 
isolated from JFBE and identifiedusing 1D and 2D 1H- and 13C-NMR. The 
administration of JFEE or JFBE to Streptozotocin (STZ)-diabetic rats 
significantly reduced fasting blood glucose (FBG) from 200 to 56 and 79 
mg%, respectively; elevated insulin from 10.8 to 19.5 and 15.1 μU/ml, 
respectively; decreased lipid peroxides from 7.3 to 5.4 and 5.9 nmol/ml, 
respectively; decreased %glycosylated hemoglobin A1C (%HbA1C) from 6.8 
to 4.5 and 5.0%, respectively; and increased total protein content from 2.5 to 
6.3 and 5.7 mg%, respectively. Triglycerides (TG), total cholesterol (TC), low-
density lipoprotein cholesterol (LDL-C), VLDL-C, and LDL/HDL ratio 
significantly declined by -37, -19, -23, -37, and -39%, respectively, in the case 
of JFEE; and by -31, -14, -17, -31, and -25%, respectively, in the case of 
JFBE; as compared to diabetic rats. HDL-C increased by +37% (JFEE) and 
by +11% (JFBE). Both JFEE and JFBE have shown appreciable results in 
decreasing FBG, lipid peroxides, %HbA1C, TC, LDL-C, and TG levels, and 
increasing insulin, HDL-C, and protein content. The spectrometric analysis 
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confirmed that the flavonoid isolated from JFBE was isoquercitrin. We can 
conclude from this study that JFEE and JFBE exert hypoglycemic and 
hypolipidemic effects in STZ-diabetic rats through an antioxidative pathway 
that might be referred to their flavonoid contents. 
 
Boopathy raja et al.,(2004)23 Herbal medicines have good curative effect on 
certain diseases especially for diabetes mellitus which needs continuous 
medication throughout the life. Present day allopathic medicines are costlier 
and having more side effects which could cause severe damages to the vital 
organs. Hence, finding a suitable herbal medicine for diabetes mellitus is very 
important in the current situation. In this present study, the fruit extract of 
Helicteres isora was used to evaluate the antihyperlipidemic activity in 
streptozotocin induced diabetic rats.  Powdered fruits of Helicteres isora were 
extracted in ethanol and the crude extract was used for the treatment of 
diabetic rats. Streptozotocin was used to induce the diabetic condition in 
wistar rats. For the treatment, the drug glibenclamide also used to treat the 
diabetic rats to compare the efficacy of the herbal extract. After 45 days of 
treatment, the animals were sacrificed and lipid profiles were estimated in the 
serum and liver. The serum and liver lipid levels were abnormal in 
streptozotocin induced diabetic rats than in the control rats. Total cholesterol, 
triglycerides, phospholipids, LDL and VLDL were elevated and the HDL level 
was significantly decreased in diabetic rats. After treated with Helicteres isora 
fruit extract (HiFE), the lipid levels of diabetic rats were restored to near 
normal level.  HiFE has the potential of antihyperlipidemic activity which was 
proved by the above results. It is suggested that HiFE may have the similar 
action mechanism of glibenclamide. 
 
Bramha et al.,(2002)22 The anti-hyperlipidemic effect of methanolic extract of 
whole plant of Rhinacanthus nasutus ((RNM) was tested in Triton and fat diet 
induced hyperlipidemic rat models. Here, Acute hyperlipidemia was induced 
by administration of single dose of Triton X 100 (400 mg/kg,i.p) and Chronic 
hyperlipidemia was induced by feeding fat diet for 21 days to rats. Treatment 
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with RNM (200 and 400 mg/kg, p.o ) significantly reduced the hyperlipidemia 
i.e., decreased levels of serum Total Cholesterol, Triglycerides, Low Density 
Lipoprotein Cholesterol (LDL-C), Very Low Density Lipoprotein Cholesterol 
(VLDL-C) , and increase of serum High Density Lipoprotein Cholesterol (HDL-
C) when 
compared to vehicle control and standard drug Atorvastatin (10 mg/kg). The 
results demonstrated that methanolic extract of whole plant of Rhinacanthus 
nasutus possessed significant antihyperlipidemic activity. 
 
Syed et al.,(2000)26 designed to perform preliminary phytochemical 
screening, acute oral toxicity and to evaluate antihyperglycemic activity of 
whole plant of Glycosmis pentaphylla ethanolic extract. .Glycosmis 
pentaphylla,whole plant was extracted using ethanol as solvent by soxhlet 
apparatus. The extract was subjected to preliminary phytochemical screening. 
Acute oral toxicity studies were performed to determine test dose .The 
evaluation of antihyperlipidemic activity was done using Triton X 100 and High 
Fat Diet induced hyperlipidemia models in Wistar albino rats. Preliminary 
phytochemical screening revealed the presence of alkaloids, carbohydrates, 
glycosides, saponins, tannins, flavonoids, proteins, and amino acids. Doses 
up to 2000mg/kg were found to be safe after acute toxicity tests. Cholesterol, 
triglycerides, HDL, LDL, VLDL, SGOT, SGPT, Total protein and glucose were 
measured. The results suggested that EGP (ethanolic extract.Glycosmis 
pentaphylla) possess antihyperlipidemic activity against hyperlipidemia 
induced by Triton X 100 and also High Fat Diet induced experimental models. 
 
Sivaelango et al.,(2014)26  Hyperlipidaemia is the greatest risk factor of 
coronary heart disease. Currently available hypolipidaemic drugs have been 
associated with number of side effects. Herbal treatment for hyperlipidaemia 
has no side effects and is relatively cheap and locally available. Literature 
claims that Saponins are able to reduce hyperlipidemia. Based on high 
saponin content in herbal plants, Spermacoce hispida (S. hispida) was 
selected and the present study focus on the antihyperlipidaemic activity of 
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ethanolic seed extract of S. hispida against triton-WR-1339 induced 
hyperlipidaemia in rats. Hyperlipidaemia was induced in Wistar rats by 
intraperitoneal (i.p) injections of Triton WR-1339 at a dose of 400 mg/kg body 
weight. S. hispida was administered orally at a dose of 200 mg/kg to triton 
WR-1339 induced hyperlipidaemic rats. After administration of S. hispida 
shows a significant decrease in the levels of cholesterol, phospholipids, 
triglycerides, LDL, VLDL and significant increase in the level of HDL in serum 
and liver tissues against triton induced hyperlipidaemic in rats. Therefore it 
effectively suppressed the triton induced hyperlipidemia in rats, suggesting 
the potential protective role in Coronary heart disease. 
 
Nazli shahin et al.,(2013)28 Phytochemical investigation of the leaves of 
Artocarpus heterophyllus furnished six compounds from different 
combinations of petroleum ether, chloroform and methanol. Structures of 
these compounds were elucidated and established by standard spectroscopic 
methods. Isolated compounds are n-Octadec-9-enoyl α-L-
rhamnopyranoside(1), n-octadec-9,12-dienoyl-α-L-rhamnopyranoside (2), n-
octadec-9,12-dienoyl-β-D-glucopyranoside (3), n-octadec-9-enoyl-β-D-
glucopyranoside (4), n-octadec-9-enoyl-β-D-arabinopyranoside (5) and n-
octadec-9-enoyl-α-D-xylopyranoside (6) respectively. The structures of all the 
phytoconstituents are elucidated on the basis of spectral data analyses and 
chemical reactions. 
Khyati et al.,(2014)20 studied Mangifera indica L., known as mango (Family; 
Anacardiaceae), commonly used herb in ayurvedic medicine, traditionally 
used for their antidiabetic, anti-oxidant, anti-viral, cardiotonic, hypotensive, 
anti-inflammatory properties, antibacterial, antifungal, anthelmintic, 
antiparasitic, antitumor, anti HIV, antibone resorption, antispasmodic, 
antipyretic, antidiarrhoeal, antiallergic, immunomodulation, hypolipidemic, 
antimicrobial, hepatoprotective, gastroprotective effects.To investigate effect 
of aqueous extract of Mangifera indica L.leaf on high cholesterol fed diet rats. 
High cholesterol fed diet rats exhibited significant increase in total serum 
cholesterol, triglycerides, low density lipoprotein, very low density lipoprotein 
and significant decrease in high density lipoproteins. Treatment with aqueous 
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extract of Mangifera indica leaves significantly decreased total serum 
cholesterol, triglycerides, low density lipoprotein, very low density lipoprotein 
and increased in high density lipoproteins rats. Hypolipidemic activity of M. 
indica may be attributed due to presence of flavonoids, Saponins, glycosides, 
tannins, phenolics. 
 
Alma et al.,(2008)27 Hyperlipidemia plays an important role in the 
development of atherosclerosis, the main cause of death in the world. In this 
study, the lipid-lowering effect of Carica papaya leaf in rats fed with a high 
cholesterol diet was evaluated. Daily doses of C. papaya extract 0, 31, 62 or 
125 mg/kg body weight were orally administered in 300 μl polyethylene glycol 
to hypercholesterolemic rats; it was also administered 62 mg/kg body weight 
of the extract to rats with normal diet. After a 20-day treatment, the animals 
were sacrificed; blood and liver were analyzed. Hypercholesterolemic rats 
showed an increased serum and liver cholesterol, triacylglycerols, and 
atherogenic index. The C. papaya extract produced a significant decrease of 
serum and liver cholesterol concentrations in hypercholesterolemic rats, but 
did not modify serum or liver triacylglycerols; however, the extract reduced the 
atherogenic index in a dose-dependent manner. C. papaya treatment 
decreased LDL-C and increased HDL-C in serum significantly. When the 
oxygen consumption was evaluated in phosphorylating and resting states, the 
respiratory control in hypercholesterolemic rats mitochondria was lower than 
in normal diet rats. However, a higher respiratory control in hypercho- 
lesterolemic rats mitochondria was observed after C papaya treatment. The 
liver morphological data are in accordance with serum and liver biochemical 
values. Our data support that C. papaya has a significant hypocholesterolemic 
action and HDL-C raising effect on rats fed with a cholesterol- rich diet, 
however, the precise metabolites responsible of this effect remain unknown. 
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CHAPTER III 
3. AIM AND OBJECTIVE 
3.1 Aim  
To successfully evaluate the antihyperlipidemic and antioxidant activity of 
Artocarpusheterophyllus stem extract on High fat diet-induced 
hypercholesterolemia and triton induced hyperlipidaemia models. 
3.2 Objective 
1. To conduct a literature survey for establishing the relavence of the 
study. 
2. To Collection and authenticate of Artocarpusheterophyllus stem. 
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3. To successfully extract the dried stem of Artocarpusheterophyllus using 
suitable solvents. 
4. To evaluate toxicological profile of the extract.  
5. To characterize the antioxidant property of the extract.  
 
 
 
 
 
 
 
 
                                    
 
 
 
CHAPTER IV 
4. PLAN OF THE WORK 
4.1 Plan Of The Work 
 Plant collection  
 Plant authentication  
 Solvent extraction 
 Phytochemical screening 
 Acute toxicological studies 
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 Pharmacological screening for antihyperlipidaemic activity   
 High-cholesterol diet induced rat model. 
 Triton induced rat model.                                      
 Effect on Normocholesteremic rats 
4.2  Pharmacological screening for antihyperlipidaemic activity   
1. Superoxide  radical scavenging activity 
2. DPPH radical reducing activity 
3. Lipid peroxidation assay 
4. Nitric oxide scavenging assay 
5. Hydrogen per oxide assay 
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              CHAPTER V 
5. PLANT  PROFILE OF ARTOCARPUS HETEROPHYLLUS 
                Table  No 3. General characters of Artocarpus Heterophyllus 
Symbol ARHE2 
Group Dicot 
Family Moraceae 
Duration Perennial 
Growth Habit Tree 
 
 
 
Rank Scientific Name and Common Name 
Kingdom Plantae – Plants 
Subkingdom Tracheobionta – Vascular plants 
Superdivision Spermatophyta – Seed plants 
Division Magnoliophyta – Flowering plants 
Class Magnoliopsida – Dicotyledons 
Subclass Hamamelididae  
Order Urticales  
Family Moraceae – Mulberry family 
Genus Artocarpus J.R. Forst. & G. Forst. – 
breadfruit 
Species Artocarpus heterophyllus Lam. – jackfruit 
Symbol Scientific  Name 
ARIN18 Artocarpus integer auct. 
ARIN20 Artocarpus integrifolius auct. 
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Fig No 1. Fruits of ARTOCARPUS HETEROPHYLLUS 
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Fig No 2. Whole parts of ARTOCARPUS HETEROPHYLLUS-I 
 
 
Fig No 3. Whole parts of ARTOCARPUS HETEROPHYLLUS-II 
 
Fig No 4. Whole parts of ARTOCARPUS HETEROPHYLLUS-III 
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Fig No 5. Whole parts of ARTOCARPUS HETEROPHYLLUS-IV 
 
 
Fig No 6. Whole parts of ARTOCARPUS HETEROPHYLLUS-V 
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Fig No 7. Whole parts of ARTOCARPUS HETEROPHYLLUS-VI 
 
 
                 
Fig No 8. Whole parts of ARTOCARPUS HETEROPHYLLUS-VII 
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Fig No 9. Whole parts of ARTOCARPUS HETEROPHYLLUS-VIII 
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CHAPTER VI 
6.MATERIALS AND METHODS 
6.1 Solvent Extraction And Phytochemical Screening 
Plant collection and extraction Artocarpus heterophyllus were collected from 
the regions of ananthagiri hills vikarabad, Telengana. After that the plant parts 
such as leaf and bark were coarsely powdered and subjected to successive 
solvent extraction using soxhlet apparatus.  
Phytochemical screening Qualitative phytochemical screening with the extract 
of both the plants Artocarpus heterophyllus  was determined as follows: 
Carbohydrates( Anthrone method),Alkaloids( 200 mg plant material in 10 ml 
methanol ,filtered ); a 2ml filtrate + 1%HCL + steam,1 ml filtrate+6 drops of 
Mayor, s reagent/Wagner, s reagent/Dragendroff reagent,creamish 
precipitate/brownish-red precipitate/orange precipitate indicated the presence 
of respective alkaloids. Flavanoids (200 mg plant material in 10 ml ethanol, a 
2 ml filtrate + conc. HCL+ magnesium ribbon pinktomato red colour indicated 
the presence of falvanoids.Tannins, (200 mg plant material in 10 ml distilled 
water , filtered): a 2ml filtrate + 2 ml FeCl3 , blue black precipitate indicated 
the presence of tannins. Glycosides( Keller-Killani test: 2 ml filtrate+ 1 ml 
glacial acetic acid + FeCl3 + conc.H2SO4); green – blue colour indicted the 
presence of glycosides. steroids( Liebermann-Burchard reaction: 200 mg 
plant material in 10 ml chloroform, filtered );a 2ml filtrate +2 ml acetic 
anhydride +conc.H2SO4. blue ring indicated the presence of terpenoids, 
Saponins( frothing test: 0.5 ml filtrate+ 5 ml distilled water); frothing 
persistence indicated presence of saponins. Anthraquinones- 2 ml of plant 
extracts were treated with 1 ml of dilute ammonia and shaken vigorously. Pink 
red colour in the ammonical layer indicates the presence of anthraquinones. 
Cardiac glycosides (Keller-Killani test) were analysed. Anti microbial 
screening were carried out in nutrient agar media. 
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6.2 Preparation Of Artocarpus Heterophyllus Stem Extract 
The barks were initially separated from the main tree and rinsed with distilled 
water and shade dried and then homogenized into fine powder and stored in 
air tight bottles. Calculated amount of powder in contrasting amount of organic 
solvents in a conical flask and then kept in a rotary shaker at 190-220 rpm for 
24 h. And then it was filtered with the help of muslin cloth and centrifuged. 
The supernatant was collected and the solvent was evaporated by solvent 
distillation apparatus to make the final volume of one-fourth of the original 
volume. It was stored at 40 °C in air tight bottles for further studies. 
6.3 Qualitative Phytochemical Screening Of Plant Extracts 
The crude extracts of the plant were subjected to chemical tests for the 
identification of various active constituents as described below. 
Table No 4.  Qualitative test protocol 
S. 
No 
Test  Methods Used  
1 Alkaloids 
Dragendroff’s test, Wagner’s test, Mayer’s 
test 
2 Flavanoid Sulphuric acid test 
3 Steroids Liebermann Burchard test, Salkowaski test 
4 Saponins Foam Test 
5 
Phenolic 
Compounds & 
Tannins 
Bromine Water Test 
6 Fats &Oils Sudan Red III reagent Test 
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7 Glycosides Keller-killiani Test 
8 Protein 
Biuret test, Xanthophoretic test, Lead acetate 
test 
9 Carbohydrates Molisch test, Fehling test, Benedict’s test 
10 Amino Acids Ninhydrin test 
 
6.4 Acute Toxicity Studies 
6.4.1 Animals 
Healthy albino rats of either sex of 2-2½-months-old of body weight 125-150 g 
were housed in polypropylene cages at 25±5°C with light dark cycle of 12 h in 
the Animal House of the study center are to be used for the study. It should be 
acclimatized for seven days. All animals are to be given with standard rat feed 
and water ad libitum. The experiments were performed after approval of the 
protocol  by  the  minute  of  Institutional Animal  Ethics  Committee  (IAEC) 
( KU/IAEC/M.Pharm/174) and animal care wastaken as per the guidelines of 
Committee for the Purpose of Controland Supervision of Experiments on 
Animals (CPCSEA), Government of India. 
 
6.5 Study Design 
6.5.1 Acute Toxicological Studies 
Acute toxicity studies for the extracts were conducted as per OECD guidelines 
423 using Albino mice of both sex (20 -25gm). Each animal was administered 
the extracts by oral route. The animals were observed for mortality up to 72 
hrs. The ethanolic and aqueous extract was found to be safe up to 2000 
mg/kg body weight. 
6.5.2 High – Cholesterol Diet Model 
Swiss albino rats weighing (200 – 250gm) were used for a standard 
experimental method as high cholesterol diet consisting of Cholesterol (1%), 
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sodium cholate (0.5%), sucrose (30%), casein(10%), butter ( 5%) and 
standard chow diet (53.5%) for 7 days. The animals divided into three groups 
of control, test and standard drug treated animals. The studies conducted in 
two stages. In the preliminary stage effective hypolipedemic doses of test and 
standard drugs are worked out and in the final stage the effect of test and 
standard drugs are studied. The lipid profile includes total cholesterol LDL, 
HDL, VLDL and triglycerides were studied. The blood samples were collected 
after 6, 24 and 48hour of drug administration. 
Group 1: Control 
Group 2: Ethanolic extract  
Group 3: Aqueous extract  
Group 4: Standard Fenofibrate 
6.5.3 Triton Induced Hyperlipidemic Rats 
The antihyperlipidemic effects of the above extracts were evaluated in 45 
triton induced hyperlipidemic rats starved for 18hours. The rats were divided 
into 4 Groups of 5 animals each. and then injected with Triton at a dose of 
100mg/kg body weight except rats of group 1 which served as a normal 
vehicle treated group 2 and 3 were treated daily with a dose of 200 and 
400mg/kg ethanolic and aqueous extracts respectively immediately after the 
Triton injection by i.p. administration. Blood samples were collected after 6, 24 
and 48 hour of Triton injection evaluates the lipid profiles.  
Group 1: Control 
Group 2: Ethanolic extract  
Group 3: Aqueous extract  
Group 4: Standard Fenofibrate 
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6.5.4 Effect on Normocholesteremic Rats 
The hypolipedemic effects of the extracts were evaluated in 4 groups of 
Normocholesteremic rats fasted for 18hour and these studies were carried out 
as described for antihyperlipidemic effects the rats were treated orally for 7 
days with the divided doses of 200mg/kg and 400mg/kg p.o. After the end of 
the stipulated period of drug treatment, all animals were starved for 20hour 
and blood samples were collected from the puncture of retro-orbital plexus 
and analysed for blood lipid profile. 
Group 1: Control 
Group 2: Ethanolic extract  
Group 4: Standard Fenofibrate 
6.5.5 Biochemical Analysis of Serum 
Serum samples were analysed for total cholesterol, High density lipoproteins, 
Low density lipoproteins and very low density lipoproteins using standard 
enzymatic assay kit. 
6.6 Acute Toxicity 
The toxicity for the aqueous and ethanolic extracts stem of Artocarpus 
heterophyllus was determined in albino mice, maintained under standard 
conditions. The animals were fasted overnight prior to the experiment. Fixed 
dose (OCED Guideline No. 420) method of CPSEA was adopted for toxicity 
studies. 
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6.7  In Vitro Antioxidant Activities 
6.7.1 Superoxide  Radical Scavenging Activity  
6.7.1.1 Principle 
The assay is based on the ability of drug to inhibit the reduction of nitro 
blue tetrazolium (NBT) by Superoxide, which is generated by the 
reaction of photo reduction of riboflavin within the system. The 
superoxide radical thus generated reduce the NBT to a blue colored 
complex. 
6.7.1.2 Reagents 
 Nitro blue tetrazolium (NBT)   -  1.5nm  (12.3mg/10ml) 
 Riboflavin                     -   0.12µm  (4.5mg/100ml) 
 NaCN/EDTA         -   0.0015% NaCN in 0.1M EDTA 
 Phosphate buffer         -   0.06M  ( pH 7.8 ) 
6.7.1.3 Procedure 
The reaction mixture contained EDTA (0.1 M), 0.3mM NaCN, Riboflavin 
(0.12mM), NBT (1.5 n moles), Phosphate buffer (67mM, pH 7.8) and various 
concentrations of the flower extract in a final volume of 3ml. The tubes were 
illuminated under incandescent lamp for 15min. The optical density at 560 nm 
was measured before and after illumination. The inhibition of superoxide 
radical generation was determined by comparing the absorbance values of 
the control with that of seed oil extract and fraction-IV. Vitamin C was used as 
positive control. The concentration of fraction-IV required to scavenge 50% 
superoxide anion (IC50 value) was then calculated.   
 
Calculation  
  % inhibition   =     
𝑶𝑫 ࢕ࢌ 𝒄࢕࢔࢚࢘࢕࢒ − 𝑶𝑫 ࢕ࢌ ࢙𝒂࢓࢖࢒ࢋ𝑶𝑫 ࢕ࢌ 𝒄࢕࢔࢚࢘࢕࢒    × 100 
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6.8  Dpph Radical Reducing Activity  
6.8.1 Principle 
It is a rapid and simple method to measure antioxidant capacity. It 
involves the use of free radical, DPPH (2, 2- Diphenyl - 1- picrylhydrazyl) 
(Aquino et al, 2001). The odd electron in the DPPH free radical gives a strong 
absorption maximum at 517nm and is purple in color. The color turns from 
purple to yellow when the odd electron of DPPH radical becomes paired with 
hydrogen from a free radical scavenging antioxidant to form the reduced 
DPPH-H. The resulting decolourisation is stochiometric with respect to the 
number of electrons captured. 
6.8.2 Reagents 
 DPPH  -   3mg in 25ml methanol (stored in dark bottle) 
 Methanol        
6.8.3 Procedure 
Freshly prepared DPPH (187 µl) was taken in different test tubes 
protected from sunlight. To this solution added different concentrations (0, 25, 
50, 75,100,150,200µg/ml) of seed oil extract and fraction-IV. The volume was 
made up to 1ml with methanol. Keep the tubes in dark and after 20 min 
absorbance was measured at 515nm. Methanol was used as blank and 
vitamin C was used as positive control. The concentration of test materials to 
scavenge 50% DPPH radical (IC50 value) was calculated from the graph 
plotted with % inhibition against Concentration. 
 
6.9 Lipid Peroxidation Activity 
 The stocking solutions, various working conc. were produced to get 
concentration of 25, 50, 75, 100, 150 & 200 µg/ml with distilled water.  
 The standard stock solution was prepared by dissolving ascorbic acid 
(Standard Sample) in suitable solvent (methanol) with a final 
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concentration of 1000 µg/ml and different concentration of 25, 50, 75, 
100, 150 & 200 µg/ml were prepared by distilled water. 
 Potassium hydrogen phosphate (0.19 gram) was mixed with 8 gm of 
sodium chloride. To this 2.38 gm of disodium hydrogen phosphate was 
dissolved and made up to 1000 milliliter alongside DM H2O and pH was 
adjusted to 7.4 
 To a set of eight clean dry test tubes, 2 ml of 0.25Mm HCL containing 
15% trichloroacetic acid and 0.38% thiobarbituric acid were added and 
to this 1 ml of different concentrations of the test extracts were added. 
For five minutes the sample was kept. Centrifugation was done and 
absorbance of the upper layer was measured at 538 nm and the lipid 
peroxide content was found. All experiments were performed in 
triplicate. 
 
6.10 Nitric Oxide Scavenging Method 
 The stocking solutions, various working conc. were produced to avail 
concentration of 25, 50, 75, 100, 150 & 200 µg/ml with distilled water.  
 The standard stock solution was prepared by dissolving ascorbic acid 
(Standard Sample) in suitable solvent (methanol) with a final 
concentration of 1000 µg/ml and different concentration of 25, 50, 75, 
100, 150 & 200 µg/ml were prepared by distilled water. 
 Sodium nitroprusside 5mM in phosphate buffer at pH 7.4 saline was 
added with a range of concentrations of the test sample or standard 
and incubated at 25oC for 150 minutes. At regular intervals, 1.5 ml of 
samples (incubated test sample) were taken off and a poured with 1.5 
ml Griess reagent (1% Sulphanilamide, phosphoric acid (2 percent), 
and 0.1 percent NEDA 2.HCL. 
 The absorbance was read at 540 nm. The difference in the absorbance 
between test and control on nitric oxide was determined and depicted 
as percent scavenging of NO radical.  
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 Capability to scavenge the NO radical was designed by using standard 
formula .All experiments were performed in triplicate. 
 
6.11 Hydrogen Peroxide Method 
 The stocking solutions, various working conc. were produced to get 
concentration of 25, 50, 75, 100, 150 & 200 µg/ml with distilled water.  
 The standard stock solution was prepared by dissolving ascorbic acid 
(Standard Sample) in suitable solvent (methanol) with a final 
concentration of 1000 µg/ml and different concentration of 25, 50, 75, 
100, 150 & 200 µg/ml were prepared by distilled water. 
 1 ml of standard and test solution was added to 0.6 ml hydrogen 
peroxide solution. After 10 minutes the reading of the solution was read 
at 230 nanometer using UV/VIS spectrophotometer alongside a blank 
containing PBS without H2O2. 
 The percentage scavenging of hydrogen peroxide of both plant fraction 
and standard compound were determined.  
 The percentage inhibition was calculated to tests & standard making 
usage of the following formula. All experiments were performed in 
triplicate. 
 
 
Calculation  
  % inhibition   =    
𝑶𝑫 ࢕ࢌ 𝒄࢕࢔࢚࢘࢕࢒ − 𝑶𝑫 ࢕ࢌ ࢙𝒂࢓࢖࢒ࢋ𝑶𝑫 ࢕ࢌ 𝒄࢕࢔࢚࢘࢕࢒    × 100 
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6.12 Triton Induced Rat Model. 
 
6.12.1 Procedure 
Eight week old adult male albino rats of Wistar strain, weighing approximately 
150 to 200 g, were acclimatized for 7 days at room temperature (22±2ºC) and 
humidity of 45-64% in a 12- hour light/dark cycle in a room under hygienic 
condition. They were given access to water and a commercial diet ad libitum. 
The experiments were carried out in the Suran labs, Hyderabad, as per the 
guidelines of Committee for the Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA), New Delhi, India, and approved by the 
Institutional Animal Ethics Committee (IAEC). 
6.12.2 Chemicals 
Triton WR-1339 (A non-ionic detergent, Isooctyl poly oxyethylene phenol) was 
obtained from Sigma Chemicals Co, Mumbai. 
6.12.3 Induction of hyperlipidaemia 
Hyperlipidaemia was induced in Wistar rats by intraperitoneal (i.p) injections 
of Triton WR-1339 at a dose of 400 mg/kg body weight. After 72 hours of 
triton injection received a daily dose of 5% CMC in 5ml/kg body weight for 7 
days. 
6.12.4 Experimental design 
In the experiment, the rats were divided into three groups of eight rats each. 
Group I rats received 5% CMC and considered as controls, Group II rats were 
treated with Triton WR-1339 (400 mg/kg body weight with Ethanolic extract) 
and Group III rats were treated with Triton WR-1339 (400 mg/kg body weight 
with aqueous extract) and ethanolic extract of Artocarpus heterophyllus stem 
(200mg/kg body weight) and Standard fenobirate (100mg/kg body weight). 
At the end of 8th day, rats were fasted overnight and sacrificed by cervical 
dislocation. Blood was collected, and serums were separated by 
centrifugation. Liver tissues were excised immediately and rinsed in ice-chilled 
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normal saline, 500mg of the tissues were homogenized in 5.0 ml of 0.1 M 
Tris–HCl buffer (pH, 7.4). Biochemical estimations were carried out in serum 
and liver tissues, parameters such as cholesterol (Zak’s, 1977), phospholipids 
(Rouser et al., 1970), triglycerides (Rice, 1970), LDL (Friedwald Levy and 
Frederickson, 1972), VLDL (Henry et al., 1998) and HDL (Varley et al., 1980) 
were analyzed. 
 
 
6.12.5 Statistical analysis 
 
Statistical analysis was performed using one-way analysis of variance 
(ANOVA) followed by Dunnnet t test using Graph Pad prism software package 
9.05. Results were expressed as mean ± SD from 8 rats in each group. P 
values <0.05 were considered as significant. 
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CHAPTER VII 
7. RESULTS AND DISCUSSION 
7.1 Results 
The toxicity for the aqueous and ethanolic extracts stem of Artocarpus 
heterophyllus was determined in albino mice, maintained under standard 
conditions. The animals were fasted overnight prior to the experiment. Fixed 
dose (OCED Guideline No. 420) method of CPSEA was adopted for toxicity 
studies. There were no sign of toxicity for first 48 hours and no animal died on 
14 day of study at a dose of 2000 mg/kg. 
Table No 5 . Photochemical test 
S.No PHYTOCHEMICAL TEST 
EXTRACTS 
Aqueous Ethanolic 
1 Alkaloids - - 
2 Tannins - + 
3 Flavonoids - - 
4 Steroids - + 
5 Phenols + + 
6 Glycosides + + 
7 Terpenoids + + 
8 Anthraquinones - + 
9 Saponins + - 
10 Caridiac glycosides - - 
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7.2 High-Cholesterol Diet Induced Rat Model 
Group 1: animals were fed with a standard diet and was given 0.9% saline 
once daily for 8 weeks with the aid of oropharyngeal cannula. 
Groups 2: animals served as hypercholesterolemic (fed with 2% w/w pure 
cholesterol enriched diet) negative control.[17] 
The animals in group 3, 4 and 5 were fed with 2% w/w pure cholesterol 
enriched diet supplemented orally with 1 ml of the extract corresponding to 
250, 500, and 1000 mg/kg per bwt (LD50>2500.[18]), respectively, once daily 
for 8 weeks. 
Group 6 were fed with 2% w/w pure cholesterol enriched diet and 
supplemented orally with 1 ml of gemfibrozil (100 mg/kg per bwt) once daily 
for 8 weeks. 
Table No 6. Cholesterol induced diet model 
Sample Treatment (mg/kg/b.wt) 
Serum Control HC HC+ 
Ethanolic 
Extract 
HC+ 
Aqueous 
Extract 
Standard 
(GMF) 
TC 12.32±0.56 24.67±0.73 15.86±0.98 13.89±0.94 11.44±0.18 
TG 8.92±0.13 7.01±19 6.23±0.39 5.99±0.23 4.18±0.37 
LDL 4.01±0.27 9.36±0.63 4.05±0.82 4.51±0.37 4.59±0.56 
HDL 5.01±0.36 3.03±0.13 3.52±0.55 3.71±0.56 3.89±0.17 
 
    HC- High Cholesterol; GMF- Gemfibrozil; TC-total cholesterol; TG- 
triacylglycerol; LDL-   low density lipoprotein; HDL- High density lipoprotein 
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Table  No 7. Blood parameters 
 
Sample Treatment (mg/kg/b.wt) 
Serum Control HC HC+ 
Ethanolic      
Extract 
HC+ 
Aqueous 
Extract 
Standard 
(GMF) 
RBC (x 
106/μL 
7.56±0.33 5.64±0.17 6.11±0.34 6.89±0.45 7.34±0.48 
Hb (g/dl) 12.6±0.46 8.56±1.76 10.55±0.5
8 
13.22±0.7
8 
13.63±0.5
6 
PCV (%) 38±1.56 29.33±0.7
7 
36.3±1.43 35.89±0.7
7 
36.77±0.3
4 
MCV (pg) 91±0.34 70.33±0.8
7 
90.4±0.47 89.83±0.2
9 
92.38±0.5
8 
MCH (pg) 
 
29.30±0.5
6 
25.14±0.4
6 
26.31±1.8
7 
27.37±0.6
3 
30.62±1.2
0 
MCHC 
(g/dL) 
30.34±0.8
7 
26.95±1.5
6 
30.34±0.5
6 
29.57±0.3
3 
31.56±0.4
5 
WBC (x 103/ 
μL 
6.97±1.56 9.97±0.04 9.22±0.56 9.12±0.54 7.59±0.53 
Neutrophils 
(%) 
54.36±1.2
0 
34.70±0.4
2 
40.89±0.7
6 
45.35±0.7
8 
50.64±0.7
4 
Monocytes 
(%) 
6.00±2.03 4.99±0.13 5.68±0.57 5.83±0.67 5.43±0.66 
Lymphocyte
s (%) 
29.30±0.7
8 
54.0±0.56 48.87±0.5
6 
39.40±0.4
1 
32.67±0.6
2 
Eosinophils 
(%) 
1.90±0.03 2.03±0.32 1.67±0.79 2.05±0.55 1.78±0.21 
Basophils 
(%) 
0.24±0.04 0.35±0.23 0.27±0.13 0.25±0.54 0.23±0.50 
Platelets 
(x103/μL 
325±1.56 647.0±0.4
5 
415.0±0.5
8 
392.0±0.8
2 
341.4±0.1
6 
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Fig No.10 Scheme of Blood parameters 
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Table No 8: Effect of Artocarpus heterophyllus on changes in the levels 
of cholesterol and phospholipids in serum and liver tissue of control 
and experimental animal 
 
Groups Cholesterol Phospholipids 
Serum Liver Serum Liver 
Control 077±2.12 062±1.85 050±0.45 085±1.87 
Ethanolic 
extract+Triton 
099±0.33 098±0.54 065±0.58 093±0.33 
Aqueous extract+ 
Triton 
085±0.87 067±0.33 056±0.67 070±0.76 
Standard 
Fenofibrate 
070±0.23 063±1.59 049±1.62 082±1.62 
Each value is mean ± SD for eight rats in each group, one way ANOVA 
followed by Dunnet t test. 
 
Fig No 11. Scheme of Effects of Cholesterol and Phospholipids 
Control
Ethanolic extract+Triton
Aqueous extract+Triton
Standard Fenofibrate
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Table No 9: Effect of Artocarpus heterophyllus on changes in the levels 
of triglycerides and  LDL in serum and liver tissue of control and 
experimental animal 
 
Groups Triglycerides LDL 
Serum Liver Serum Liver 
Control 075±1.98 061±2.00 038±1.44 021±0.76 
Ethanolic 
extract+Triton 
097±0.65 093±0.78 065±0.39 035±0.58 
Aqueous 
extract+Triton 
088±0.57 065±1.98 060±1.52 030±1.77 
Standard 
Fenofibrate 
069±2.01 057±0.73 035±0.42 019±0.36 
Each value is mean ± SD for eight rats in each group, one way ANOVA 
followed by Dunnet t test. 
 
Fig No 12. Scheme of Effects of triglycerides and LDL 
 
Control
Ethanolic extract+Triton
Aqueous extract+Triton
Standard Fenofibrate
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Table No 10: Effect of Artocarpus heterophyllus on changes in the levels 
of VLDL and HDL in  serum and liver tissue of control and experimental 
animal 
 
Groups VLDL HDL 
Serum Liver Serum Liver 
Control 016±2.60 013±2.05 049±1.62 030±0.24 
Ethanolic 
extract+Triton 
015±0.55 014±0.73 045±1.56 026±0.56 
Aqueous 
extract+Triton 
014±1.83 011±0.56 035±0.47 020±0.35 
Standard 
Fenofibrate 
012±0.92 010±0.37 027±1.83 017±0.28 
Each value is mean ± SD for eight rats in each group, one way ANOVA 
followed by Dunnet t test. 
 
 
Fig No 13. Scheme of Effects of VLDL and HDL 
Control
Ethanolic extract+Triton
Aqueous extract+Triton
Standard Fenofibrate
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7.3 Effect On Normocholesteremic Rats 
      The hypolipidemic effects of the extracts were evaluated in 4 groups  
fasted for 18 hours and these studies were carried out as described for 
antihyperlipidemic effects. The rats were treated orally for 7 days. After the 
end of the stipulated period of drug treatment, all the animals were starved for 
20 hours and blood samples were collected  from the puncture of retro-orbital 
plexus and analyzed for blood lipid profile. 
Table No 11. Effect of the extracts on blood lipid profile 
Groups Blood lipid profile 
Cholesterol Triglycerides HDL LDL 
Control 75.53±0.35 63.24±1.66 25.76±0.88 60.45±0.23 
Ethanolic extract 70.56±0.56 56.73±0.28 29.48±0.22 49.96±0.79 
Aqueous extract 64.92±0.73 53.77±0.78 32.15±0.63 41.56±0.69 
Standard 
Fenofibrate 
63.23±0.56 50.02±0.45 31.66±0.68 39.56±0.39 
In statistical analysis the extract treated groups have been compared with 
their respective control. P<0.01 (ANOVA followed by Dunnett’s t-test) 
 63 
 
 
Fig No 14. Scheme of Blood lipid profiles 
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Fig No 15. Scheme of blood lipid profiles 
 
7.4 Outcomes 
The antihyperlipidaemic and antioxidant activity of the plant stem extract is 
studied and the significance is evaluated.  
 
 
 
 
 
            **Ascorbic acid, ethanolic extract & aqueous extract in % inhibition 
                   All the experiments were performed in triplicates 
There has been an significant inhibition of free radicals has been 
observed with the both the ethanolic and aqueous extract as compared 
with the standard ascorbic acid with the concentrations of 25, 50, 75, 
100, 150 & 200 µg/ml respectively. There has been an considerable 
inhibition of the formed free radicals with the constituents present in both 
the samples 
         Table No 12. Superoxide Radical Scavenging activity 
Conc. 
(µg/ml) 
Ascorbic 
acid 
Ethanolic 
Extract 
Aqueous 
extract 
25 73.50±0.70 46.46±0.34 24.23±1.45 
50 77.63±3.12 56.47±0.86 38.01±0.34 
75 82.33±0.96 65.00±0.87 48.44±0.14 
100 85.93±0.79 70.23±1.46 59.36±1.11 
150 93.30±0.02 73.56±1.76 68.36±1.08 
200 94.54±0.06 75.22±0.60 70.57±0.59 
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Fig No 16 . Schematic representation of superoxide radical 
scavenging activity of all the extracts 
     **Ascorbic acid, ethanolic extract & aqueous extract in % inhibition 
                     All the experiments were performed in triplicates 
There has been an significant inhibition of free radicals has been 
observed with the both the ethanolic and aqueous extract as compared 
with the standard ascorbic acid with the concentrations of 25, 50, 75, 
100, 150 & 200 µg/ml respectively. There has been an considerable 
inhibition of the formed free radicals with the constituents present in both 
the samples. Table No 13. DPPH Assay 
Conc. 
(µg/ml) 
Ascorbic acid 
 
Ethanolic 
Extract 
 
Aqueous 
extract 
 
25 66.20±0.22 61.25±0.29 66.24±0.90 
50 70.44±0.57 62.54±0.62 68.52±0.13 
75 76.22±0.67 64.22±0.56 72.44±2.76 
100 78.44±0.29 67.77±0.56 77.34±1.56 
P
e
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n
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Conc (µg/ml)  
Ascorbic acid
Ethanolic Extract
Aqueous extract
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150 87.47±1.05 74.24±2.33 85.59±1.99 
200 92.02±0.02 76.23±0.24 88.33±1.97 
 
  
 
   Fig No 17. Schematic representation of DPPH activity of all the extracts 
  **Ascorbic acid, ethanolic extract & aqueous extract in % inhibition 
                     All the experiments were performed in triplicates 
There has been an significant inhibition of free radicals has been 
observed with the both the ethanolic and aqueous extract as compared 
with the standard ascorbic acid with the concentrations of 25, 50, 75, 
100, 150 & 200 µg/ml respectively. There has been an considerable 
inhibition of the formed free radicals with the constituents present in both 
the samples.  
 Table No 14. Lipid per oxidation Assay 
Conc. 
(µg/ml) 
Ascorbic acid 
 
Ethanolic 
Extract 
 
Aqueous 
extract 
 
25 69.52±2.97 45.33±3.45 54.55±1.36 
50 74.56±1.93 53.34±1.25 61.50±1.50 
P
e
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e
n
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e
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Conc (µg/ml)  
Ascorbic acid
Ethanolic Extract
Aqueous extract
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75 80.47±0.48 61.45±1.34 69.45±1.78 
100 83.32±1.62 66.77±1.36 74.38±0.56 
150 87.52±0.35 74.28±3.46 85.67±1.91 
200 89.67±0.46 78.54±0.87 86.33±0.73 
 
Fig No 18. Schematic representation of Lipid per oxidation Assay of 
all the extracts 
**Ascorbic acid, ethanolic extract & aqueous extract in % inhibition 
                     All the experiments were performed in triplicates 
There has been an significant inhibition of free radicals has been 
observed with the both the ethanolic and aqueous extract as compared 
with the standard ascorbic acid with the concentrations of 25, 50, 75, 
100, 150 & 200 µg/ml respectively. There has been an considerable 
inhibition of the formed free radicals with the constituents present in both 
the samples.  
Table No 15. Nitric oxide scavenging assay 
Conc. 
(µg/ml) 
Ascorbic acid 
 
Ethanolic 
Extract 
 
Aqueous 
extract 
 
25 43.50±0.62 30.62±0.56 35.33±2.56 
P
e
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e
n
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Conc (µg/ml)  
Ascorbic acid
Ethanolic Extract
Aqueous extract
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50 55.36±1.57 36.57±0.33 49.44±0.45 
75 68.22±0.32 42.67±1.56 60.67±0.77 
100 80.12±0.66 50.28±1.36 72.53±1.32 
150 91.56±0.23 60.12±0.38 
89.35±1.66 
200 95.33±2.34 69.88±0.34 93.44±0.65 
 
Fig No 19. Schematic representation of Nitric oxide scavenging 
assay of all the extra 
                **Ascorbic acid, ethanolic extract & aqueous extract in % inhibition 
                     All the experiments were performed in triplicates 
There has been an significant inhibition of free radicals has been 
observed with the both the ethanolic and aqueous extract as compared 
with the standard ascorbic acid with the concentrations of 25, 50, 75, 
100, 150 & 200 µg/ml respectively. There has been an considerable 
inhibition of the formed free radicals with the constituents present in both 
the samples.  
Table No 16. Hydrogen per oxide assay 
Conc. 
(µg/ml) 
Ascorbic acid 
 
Ethanolic 
Extract 
 
Aqueous 
extract 
 
P
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n
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Conc (µg/ml)  
Ascorbic acid
Ethanolic Extract
Aqueous extract
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25 48.66±0.22 39.56±0.34 45.09±0.42 
50 58.32±0.68 46.58±1.26 53.60±1.52 
75 67.99±1.66 54.88±1.62 62.36±1.67 
100 73.56±0.12 60.97±1.42 69.56±0.79 
150 81.62±0.26 69.49±1.31 
77.93±1.74 
200 85.57±0.12 75.45±0.38 83.49±0.57 
 
\             
Fig No 20. Schematic representation of Hydrogen peroxide assay of all 
the extracts 
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CHAPTER VIII 
8. SUMMARY AND CONCLUSION 
From the experimental and research revealing of the entire study of 
Atrocarpus Hetrophyllus indicated the presence of antihyperlipidemic activity 
and and the potential antioxidant activity as a whole. Various antioxidant 
invitro studies performed onto the Atrocarpus Hetrophyllus indicates that as 
compared to the ascorbic acid the radical scavenging activity are proven well, 
and it is comparatively equivalent to the Standard drug. 
Animal studies performed on the particular extracts of Atrocarpus 
Hetrophyllus revealed that the antihyperlipidemic activity is very potential and 
found to be significantly reducing the triglycerides levels of all the animal 
group given with the prepared extracts, Hence the animal group administered 
with higher extract will be shown an increased activity as compared with the 
extract given in less equlavent and as compared with the standard 
antihyperglycemic drug as well. 
Hence it is concluded that the potential benefits of the extracts of Atrocarpus 
Hetrophyllus has been demonstrated well in advance and can be used further 
to demonstrate the antihyperlipidemic as well as the antioxidant activity for the 
controlling of both triglyceride levels and reducing the risk of generation of 
ROS against the free radicals. 
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The aforementioned results of the research suggest that the Atrocarpus 
Hetrophyllus, found to have the potential antihyperlipidemic and antioxidant 
activity. 
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